These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Stone GW; White HD; Ohman EM; Bertrand ME; Lincoff AM; McLaurin BT; Cox DA; Pocock SJ; Ware JH; Feit F; Colombo A; Manoukian SV; Lansky AJ; Mehran R; Moses JW; Lancet; 2007 Mar; 369(9565):907-19. PubMed ID: 17368152 [TBL] [Abstract][Full Text] [Related]
5. Bivalirudin in PCI: an overview of the REPLACE-2 trial. Maroo A; Lincoff AM Semin Thromb Hemost; 2004 Jun; 30(3):329-36. PubMed ID: 15282655 [TBL] [Abstract][Full Text] [Related]
6. Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial. Chacko M; Lincoff AM; Wolski KE; Cohen DJ; Bittl JA; Lansky AJ; Tsuchiya Y; Betriu A; Yen MH; Chew DP; Cho L; Topol EJ Am Heart J; 2006 May; 151(5):1032.e1-7. PubMed ID: 16644331 [TBL] [Abstract][Full Text] [Related]
7. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. Gibson CM; Morrow DA; Murphy SA; Palabrica TM; Jennings LK; Stone PH; Lui HH; Bulle T; Lakkis N; Kovach R; Cohen DJ; Fish P; McCabe CH; Braunwald E; J Am Coll Cardiol; 2006 Jun; 47(12):2364-73. PubMed ID: 16781360 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice. Kim LK; Wong SC; Minutello RM; Bergman G; Feldman DN J Invasive Cardiol; 2010 Mar; 22(3):94-100. PubMed ID: 20197573 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of randomized clinical trials comparing bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention and in patients with ST-segment elevation myocardial infarction. Nairooz R; Sardar P; Amin H; Swaminathan RV; Kim LK; Chatterjee S; Feldman DN Am J Cardiol; 2014 Jul; 114(2):250-9. PubMed ID: 24890986 [TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial. Cohen DJ; Lincoff AM; Lavelle TA; Chen HL; Bakhai A; Berezin RH; Jackman D; Sarembock IJ; Topol EJ J Am Coll Cardiol; 2004 Nov; 44(9):1792-800. PubMed ID: 15519009 [TBL] [Abstract][Full Text] [Related]
11. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. Stone GW; Ware JH; Bertrand ME; Lincoff AM; Moses JW; Ohman EM; White HD; Feit F; Colombo A; McLaurin BT; Cox DA; Manoukian SV; Fahy M; Clayton TC; Mehran R; Pocock SJ; JAMA; 2007 Dec; 298(21):2497-506. PubMed ID: 18056903 [TBL] [Abstract][Full Text] [Related]
12. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy. Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ; J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319 [TBL] [Abstract][Full Text] [Related]
13. Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention. Feldman DN; Wong SC; Bergman G; Minutello RM J Invasive Cardiol; 2009 Jun; 21(6):258-63. PubMed ID: 19494400 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: an analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial. Rajagopal V; Lincoff AM; Cohen DJ; Gurm HS; Hu T; Desmet WJ; Kleiman NS; Bittl JA; Feit F; Topol EJ Am Heart J; 2006 Jul; 152(1):149-54. PubMed ID: 16824845 [TBL] [Abstract][Full Text] [Related]
16. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study). Patti G; Pasceri V; D'Antonio L; D'Ambrosio A; Macrì M; Dicuonzo G; Colonna G; Montinaro A; Di Sciascio G Am J Cardiol; 2012 Aug; 110(4):478-84. PubMed ID: 22583760 [TBL] [Abstract][Full Text] [Related]
17. Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions. Kao J; Lincoff AM; Topol EJ; Madrid A; J Price M; Sawhney N; Teirstein PS Catheter Cardiovasc Interv; 2006 Sep; 68(3):352-6. PubMed ID: 16892428 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. White HD; Ohman EM; Lincoff AM; Bertrand ME; Colombo A; McLaurin BT; Cox DA; Pocock SJ; Ware JA; Manoukian SV; Lansky AJ; Mehran R; Moses JW; Stone GW J Am Coll Cardiol; 2008 Sep; 52(10):807-14. PubMed ID: 18755342 [TBL] [Abstract][Full Text] [Related]
19. Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: a meta-regression analysis of randomized trials. Tarantini G; Brener SJ; Barioli A; Gratta A; Parodi G; Rossini R; Navarese EP; Niccoli G; Frigo AC; Musumeci G; Iliceto S; Stone GW Am Heart J; 2014 Mar; 167(3):401-412.e6. PubMed ID: 24576526 [TBL] [Abstract][Full Text] [Related]
20. Bivalirudin for patients with acute coronary syndromes. Stone GW; McLaurin BT; Cox DA; Bertrand ME; Lincoff AM; Moses JW; White HD; Pocock SJ; Ware JH; Feit F; Colombo A; Aylward PE; Cequier AR; Darius H; Desmet W; Ebrahimi R; Hamon M; Rasmussen LH; Rupprecht HJ; Hoekstra J; Mehran R; Ohman EM; N Engl J Med; 2006 Nov; 355(21):2203-16. PubMed ID: 17124018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]